 |
Candi-Trol
by Douglas Labs
90 Tablets
Support For Intestinal Health*
| Our Price: $19.20 | 
|
Candi-Trol, provided by Douglas Laboratories, contains a significant amount of caprylic acid together with other synergistic nutrients meant to
support a healthy intestinal microflora. Potassium sorbate is included as a natural stabilizer.*
In healthy people, the intestinal microflora consists of balanced amounts of symbiotic microorganisms, providing nutritional benefits to the host. This balance depends on our dietary habits and can easily be disturbed by unhealthy diets or drugs, such as antibiotics and oral contraceptives. Under these conditions, opportunistic pathogenic microorganisms, such as the fungus Candida albicans, can colonize the small and large intestine.*
Caprylic acid (octanoic acid), commonly found in foods such as coconut oil, milk fat, etc., is a natural dietary fatty acid which helps maintain a normal intestinal microflora. Studies have shown that dietary caprylic acid helps inhibit the growth of Candida albicans and other opportunistic fungi in both the small and large intestine. At the same time, caprylic acid does not adversely affect the growth of beneficial intestinal bacteria.*
Dietary zinc, essential for optimum immune function, has been shown to be effective in reducing susceptibility to opportunistic microorganisms, such as Candida, especially in those individuals with compromised immune systems. Studies have described clinical improvement with biotin supplementation of individuals with immune deficiencies associated particularly with carboxylase dysfunction.*
Vitamins C and E, together with magnesium and calcium, are included in the formulation to offer metabolic support not only for a healthy immune system, particularly involving the thymus, but also for the maintenance of optimal structure and function of the intestine to help successfully resist opportunistic Candida microorganisms.
|
|
Supplement FactsServing Size: One (1) Tablet
Servings Per Container: 90 | | | | Amount
Per Serving | Daily
Value | Vitamin C
(Ascorbic Acid) | 25 mg | 42% | Vitamin E
(As Vitamin E Succinate) | 10 IU | 33% | | Biotin | 300 mcg | 100% | Calcium
(From Calcium Caprylic Acid Complex) | 60 mg | 6% | Magnesium
(From Magnesium Aspartate Complex) | 30 mg | 8% | Zinc
(From Zinc Aspartate Complex) | 5 mg | 33% | Potassium
(From Potassium Sorbate) | 65 mg | 2% | | | Caprylic Acid | 100 mg | ** | |
** Daily Value Not Established. Percent Daily Values are based on a 2,000 calorie diet. |
|
 |
|
|
| Also contains Cellulose, Vegetable Stearate and Silica. This product contains NO yeast, wheat gluten, soy protein, milk/dairy, corn, sodium, sugar, starch, artificial flavoring, preservatives or flavoring. |
| |
| As a dietary supplement, adults take One (1) tablet Three (3) times dailiy or as directed by your healthcare professional. |
| |
| KEEP OUT OF REACH OF CHILDREN. Store in a cool, dry place. |
| |
| This product contains NO yeast, wheat gluten, soy protein, milk/dairy, corn, sodium, sugar, starch, artificial flavoring, preservatives or flavoring.Meets Douglas Laboratories spec [#7006]. Conforms to USP for disintegration. |
|
|
|
| Immune System Support, Immunodeficiency, Intestinal Distress, Microbial Imbalances |
| |
| Immune System, Intestinal Lining, Intestinal Mucous Membrane, Intestine, Thymus |
| |
Clohessy, PA, Golden, BE. The mechanism of calprotectin's candidastatic activity appears to involve zinc chelation. Biochem Soc Trans 1996;24:309S.
Cowan, MJ, Wara, DW, Packman, S, Ammann, AJ, Yoshino, M, Sweetman, L, Nyhan, W. Multiple biotin-dependent carboxylase deficiencies associated with defects in T-cell and B-cell immunity. Lancet 1979;2:115-8.
Gafar, M, Dumitriu, H, Dumitriu, S, Guti, L. [Apiphytotherapeutic original preparations in the treatment of chronic marginal parodontopathies. A clinical and microbiological study]. Rev Chir Oncol Radiol O R L Oftalmol Stomatol Ser Stomatol 1989;36:91-8.
Keeney, E. Sodium caprylate: A new and effective treatment for moniliasis of the skin and mucous membranes. Bull Johns Hopkins Hosp 1946;78:333-339.
Mocchegiani, E, Muzzioli, M. Therapeutic application of zinc in human immunodeficiency virus against opportunistic infections. J Nutr 2000;130:1424S-31S.
Mocchegiani, E, Muzzioli, M, Gaetti, R, Veccia, S, Viticchi, C, Scalise, G. Contribution of zinc to reduce CD4+ risk factor for 'severe' infection relapse in aging: parallelism with HIV. Int J Immunopharmacol 1999;21:271-81.
Mocchegiani, E, Veccia, S, Ancarani, F, Scalise, G, Fabris, N. Benefit of oral zinc supplementation as an adjunct to zidovudine (AZT) therapy against opportunistic infections in AIDS. Int J Immunopharmacol 1995;17:719-27.
Munnich, A, Saudubray, JM, Ogier, H, Coude, FX, Marsac, C, Roccichioli, F, Labarthe, JC, Cazenave, C, Laugier, J, Charpentier, C, Frezal, J. [Multiple biotin-dependent carboxylase deficiencies (author's transl)]. Arch Fr Pediatr 1981;38:83-90.
Neuhauser, I, Gustus, E. Treatment of intestinal moniliasis with fatty acid resin complex. Arch Intern Med 1954;93:53-60.
Tsukahara, T. Fungicidal action of caprylic acid for Candida albicans. Japan J Microbiol 1961;5:383-394. |
| |
| http://securepics.org/__images/DouglasLabs/_labels/CVSupportPack_DL2455030X_LABEL.png |
|
 |
Our Price: $19.20 |
|
|
|
|
